KRAS and colorectal carcinoma: Molecular markers such as K-Ras, N-Ras, B-Raf, HER2, and MSI play a significant role in the disease prognosis in CRC, and hence, analysis of these biomarkers helps in facilitating proper treatment to the needy patients [30].